Vanguard Personalized Indexing Management, LLC Bio N Tech Se Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 2,164 shares of BNTX stock, worth $223,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,164Holding current value
$223,649% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding BNTX
# of Institutions
317Shares Held
40.7MCall Options Held
1.39MPut Options Held
1.52M-
Baillie Gifford & CO7.88MShares$814 Million0.61% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$437 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$414 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$372 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$196 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...